Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective cohort study and analysis of transcriptomic predictors of response
Drennan P. et al, (2024), Lancet microbe
In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review.
Drennan PG. et al, (2023), Clin transl sci, 16, 357 - 382
In vivo human keyhole limpet haemocyanin challenge in early phase drug development: A systematic review
Drennan P. et al, (2022), Clinical and translational science
Assessment of an institutional guideline for vancomycin dosing and identification of predictive factors associated with dose and drug trough levels.
Gu Q. et al, (2022), J infect, 85, 382 - 389
Mycobacterium tuberculosis transmission in Birmingham, UK, 2009-19: An observational study.
Walker TM. et al, (2022), Lancet reg health eur, 17
Population pharmacokinetics of free flucloxacillin in patients treated with oral flucloxacillin plus probenecid.
Drennan PG. et al, (2021), Br j clin pharmacol, 87, 4681 - 4690
Predictive Performance of Bayesian Vancomycin Monitoring in the Critically Ill.
Narayan SW. et al, (2021), Crit care med, 49, e952 - e960
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.
Lumley SF. et al, (2021), Clin infect dis, 73, e699 - e709
Bayesian Forecasting for Intravenous Tobramycin Dosing in Adults With Cystic Fibrosis Using One Versus Two Serum Concentrations in a Dosing Interval.
Drennan PG. et al, (2021), Ther drug monit, 43, 505 - 511
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study.
Eyre DW. et al, (2020), Elife, 9
The dosing and monitoring of vancomycin: what is the best way forward?
Drennan PG. et al, (2019), Int j antimicrob agents, 53, 401 - 407
Total flucloxacillin plasma concentrations poorly reflect unbound concentrations in hospitalized patients with Staphylococcus aureus bacteraemia.
Chin PKL. et al, (2018), Br j clin pharmacol, 84, 2311 - 2316